---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-026868"
form_type: "8-K"
ticker: "HOTH"
cik: "0001711786"
company_name: "Hoth Therapeutics, Inc."
filed_at: "2024-03-28T23:59:59+00:00"
generated_at: "2026-06-04T06:15:39.689414+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Hoth Therapeutics raises $4.2M via warrant exercise inducement, issues new warrants for 3.75M shares

## Summary
- Gross proceeds of ~$4.2M from immediate cash exercise of 2.5M existing warrants at reduced exercise price of $1.6775 (down from $5.00).
- Company issues new unregistered warrants to purchase up to 3.75M shares at $1.50, exercisable immediately until July 3, 2028.
- Offering expected to close on or about April 1, 2024; H.C. Wainwright acting as exclusive placement agent.
- Net proceeds used for general working capital purposes.
- Company agreed to file resale registration statement for shares underlying new warrants within 30 days of closing.

## SEC filing metadata
- accession: 0001213900-24-026868
- form_type: 8-K
- ticker: HOTH
- cik: 0001711786
- company_name: Hoth Therapeutics, Inc.
- filed_at: 2024-03-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711786/000121390024026868/0001213900-24-026868-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711786/000121390024026868/ea0202788-8k_hoththera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-026868
- JSON: https://secwatch.observer/filing/0001213900-24-026868.json
- Plain text: https://secwatch.observer/filing/0001213900-24-026868.txt

## Key facts
- Material Agreements
  Hoth Therapeutics, Inc. entered into Inducement Letter with a certain holder of existing warrants valued at aggregate gross proceeds of approximately $4.2 million (effective 2024-03-27).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain holder of existing warrants
  - Value: aggregate gross proceeds of approximately $4.2 million
  - Effective: 2024-03-27
  source text: On March 27, 2024, Hoth Therapeutics, Inc., a Nevada corporation (the “ Company ”), entered into an inducement offer letter agreement (the “ Inducement Letter ”) with a certain holder (the “ Holder ”) of existing warrants (the “ Existing Warrants ”) to purchase shares of common stock of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1711786/000121390024026868/0001213900-24-026868-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.